Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design

Cover Page

Cite item

Full Text

Abstract

Aim. To compare efficiency and specific features of transthyretin amyloid staining by different histological dyes and thus to assess their suitability for diagnostic purposes.

Materials and methods. Samples of left and right heart ventricles were taken from patients over 70 years-old of both genders (n=10) with immunohistochemically verified transthyretin amyloidosis (ATTR). All samples were stained with Congo red, Alcian blue, toluidine blue and methylene violet.

Results. Specificity and sensitivity of Congo red staining was comparable to those of immunohistochemical staining. For verification of amyloid presence after Congo red staining one could use fluorescent microscopy instead of polarization microscopy. It allows a more accurate diagnosis of amyloidosis. Confocal microscopy with spectral unmixing improves detection sensitivity of amyloid by elimination of background fluorescence of muscle tissue and autofluorescence of lipofuscin. Alcian blue staining gives the same result as Congo red. In addition, it’s less labor-intensive and free of false-positive and false-negative results caused by final processing of slide preparation. Toluidine blue and methylene violet develop metachromatic staining upon binding to transthyretin fibrils, likely due to specific biochemical features of these fibrils.

Conclusion. The most reliable method for histochemical diagnosis of ATTR is the Congo red staining with subsequent analysis using fluorescence or confocal microscopy. For diagnostic screening, the use of Sodium sulphate-Alcian blue staining method is highly promising. Metachromatic stains are less effective for ATTR diagnosis.

About the authors

Valeriia V. Guselnikova

Institute of Experimental Medicine

Author for correspondence.
Email: Guselnicova.Valeriia@yandex.ru
ORCID iD: 0000-0002-9499-8275

канд. биол. наук, ст. науч. сотр. лаб. функциональной морфологии центральной и периферической нервной системы отд. общей и частной морфологии

Russian Federation, Saint Petersburg

Elena A. Fedorova

Institute of Experimental Medicine

Email: Guselnicova.Valeriia@yandex.ru
ORCID iD: 0000-0002-0190-885X

канд. биол. наук, науч. сотр. лаб. функциональной морфологии центральной и периферической нервной системы отд. общей и частной морфологии

Russian Federation, Saint Petersburg

Alexandra Ja. Gudkova

Pavlov First Saint Petersburg State Medical University

Email: Guselnicova.Valeriia@yandex.ru
ORCID iD: 0000-0003-0156-8821

д-р мед. наук, проф. каф. факультетской терапии, зав. лаб. кардиомиопатий НИИ сердечно-сосудистых заболеваний Научно-клинического исследовательского центра

Russian Federation, Saint Petersburg

Michael M. Shavlovsky

Institute of Experimental Medicine

Email: Guselnicova.Valeriia@yandex.ru
ORCID iD: 0000-0002-2119-476X

д-р мед. наук, проф., зав. лаб. молекулярной генетики человека отд. молекулярной генетики

Russian Federation, Saint Petersburg

Dmitrii E. Korzhevskii

Institute of Experimental Medicine; Pavlov First Saint Petersburg State Medical University

Email: Guselnicova.Valeriia@yandex.ru
ORCID iD: 0000-0002-2456-8165

д-р. мед. наук, проф., проф. РАН, зав. лаб. функциональной морфологии центральной и периферической нервной системы отд. общей и частной морфологии, вед. науч. сотр. лаб. кардиомиопатий НИИ сердечно-сосудистых заболеваний

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. Narotsky DL, Castano A, Weinsaft JW, et al. Wild-type Transthyretin Cardiac Amyloidosis: Novel Insights from Advanced Imaging. Can J Cardiol. 2016;32(9):1-10. doi: 10.1016/j.cjca.2016.05.008
  2. Halatchev IG, Zheng J, Ou J. Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies. J Thorac Dis. 2018;10(3):2034-45. doi: 10.21037/jtd.2018.03.134
  3. Cornwell GG 3rd, Murdoch WL, Kyle RA, et al. Frequency and distribution of senile cardiovascular amyloid: a clinicopathologic correlation. Am J Med. 1983;75:618-62. doi: 10.1016/0002-9343(83)90443-6
  4. Banypersad SM, Moon JC, Whelan C, et al. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012;1(2):e000364. doi: 10.1161/JAHA.111.000364
  5. Полякова А.А., Семернин Е.Н., Ситникова М.Ю., и др. Транстиретиновый амилоидоз в когорте пациентов с хронической сердечной недостаточностью старческого возраста и долгожителей. Кардиология. 2018;58(S2):12-8 [Poliakova AA, Semernin EN, Sitnikova MYu, et al. Transthyretin amyloidosis in a cohort of old and very old patients with chronic heart failure. Kardiologiia. 2018;58(S2):12-8 (in Russian)]. doi: 10.18087/cardio.2390
  6. Liu PP, Smyth D. Wild-Type Transthyretin Amyloid Cardiomyopathy. A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications. Circulation. 2016;133(3):245-7. doi: 10.1161/CIRCULATIONAHA.115.020351
  7. Рамеев В.В., Козловская Л.В., Жданова Е.А., Гудкова К.В. Кардиоренальные взаимосвязи при системном амилоидозе. Терапевтический архив. 2013;85(6):51-9 [Rameev VV, Kozlovskaia LV, Zhdanova EA, Gudkova KV. Cardiorenal links in systemic amyloidosis. Terapevticheskii Arkhiv (Ter. Arkh.). 2013;85(6):51-9 (in Russian)].
  8. Yakupova EI, Bobyleva LG, Vikhlyantsev IM, Bobylev AG. Congo Red and amyloids: history and relationship. Biosci Rep. 2019;39(1):BSR20181415. doi: 10.1042/BSR20181415
  9. Pomerance A, Slavin G, McWatt J. Experience with the sodium sulphate-Alcian Blue stain for amyloid in cardiac pathology. J Clin Pathol. 1976;29(1):22-6. doi: 10.1136/jcp.29.1.22
  10. Wolman M. Amyloid, its nature and molecular structure. Comparison of a new toluidine blue polarized light method with traditional procedures. Lab Invest. 1971;25(2):104-10.
  11. Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016;23(4):209-13. doi: 10.1080/13506129.2016.1257986
  12. Howie AJ, Owen-Casey MP. 'Apple-green birefringence' of amyloid stained by Congo red. Kidney Int. 2012;82(1):114;author reply 114. doi: 10.1038/ki.2012.89
  13. Cohen AS, Calkins E, Levene CI. Studies on experimental amyloidosis. Analysis of histology and staining reactions of caseininduced amyloidosis in the rabbit. Am J Pathol. 1959;35:971-89.
  14. Elghetany MT, Saleem A. Methods for staining amyloid in tissues: a review. Stain Technol. 1988;63(4):201-12. doi: 10.3109/10520298809107185
  15. Sridharan G, Shankar AA. Toluidine blue: A review of its chemistry and clinical utility. J Oral Maxillofac Pathol. 2012;16(2):251-5. doi: 10.4103/0973-029X.99081

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Transthyretin amyloidosis of the human myocardium. Immunohistochemical reaction for aggregated transthyretin, staining of nuclei with Ehrlich's hematoxylin: a – total amyloid myocardial damage; b – focal accumulations of amyloid in the myocardium; c, d – amyloid accumulations in the walls of myocardial blood vessels.

Download (366KB)
3. Fig. 2. Amyloid aggregates stained with Congo red in the human myocardium. Stained with 0.1% aqueous solution of Congo red: a, b – light microscopy; c – fluorescence microscopy; d, e – confocal laser microscopy (spectral unmixing). A diode laser with a wavelength of 561 nm (red color) was used to excite the fluorescence of Congo red, and a diode laser with a wavelength of 488 nm was used to excite the autofluorescence of muscle tissue.

Download (408KB)
4. Fig. 3. Amyloid accumulations in the human myocardium, stained with different histochemical stains: a, b – Alcian blue stained with picric acid (a) or nuclear strong red (b); amyloid stained turquoise (a) or blue (b); c, d – stained with toluidine blue, amyloid stained light purple; e, f – staining with methyl violet, amyloid is stained in saturated violet. The arrow points to the mast cell with signs of degranulation.

Download (468KB)

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies